| Application number | Title of the application | Filing Date | Status |
|---|
| 09/806228 | Novel antibodies, drugs containing these antibodies and methods for screening compounds by using these antibodies | Mar 27, 2001 | Abandoned |
Array
(
[id] => 6342248
[patent_doc_number] => 20020034765
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-21
[patent_title] => 'Method for reducing the immunogenicity of antibody variable domains'
[patent_app_type] => new
[patent_app_number] => 09/810502
[patent_app_country] => US
[patent_app_date] => 2001-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 10822
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0034/20020034765.pdf
[firstpage_image] =>[orig_patent_app_number] => 09810502
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/810502 | Method for reducing the immunogenicity of antibody variable domains | Mar 15, 2001 | Issued |
Array
(
[id] => 6496280
[patent_doc_number] => 20020025319
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Antibodies that bind phosphatidyl serine and a method of their use'
[patent_app_type] => new
[patent_app_number] => 09/805217
[patent_app_country] => US
[patent_app_date] => 2001-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8450
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0025/20020025319.pdf
[firstpage_image] =>[orig_patent_app_number] => 09805217
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/805217 | Antibodies that bind phosphatidyl serine and a method of their use | Mar 13, 2001 | Abandoned |
Array
(
[id] => 7092403
[patent_doc_number] => 20010033842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-25
[patent_title] => 'Method of treating allergic disorders'
[patent_app_type] => new
[patent_app_number] => 09/802077
[patent_app_country] => US
[patent_app_date] => 2001-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 21673
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0033/20010033842.pdf
[firstpage_image] =>[orig_patent_app_number] => 09802077
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/802077 | Method of treating allergic disorders | Mar 7, 2001 | Issued |
Array
(
[id] => 1238596
[patent_doc_number] => 06685939
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-02-03
[patent_title] => 'Method of preventing the onset of allergic disorders'
[patent_app_type] => B2
[patent_app_number] => 09/802096
[patent_app_country] => US
[patent_app_date] => 2001-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 9
[patent_no_of_words] => 23479
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 494
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/685/06685939.pdf
[firstpage_image] =>[orig_patent_app_number] => 09802096
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/802096 | Method of preventing the onset of allergic disorders | Mar 7, 2001 | Issued |
Array
(
[id] => 6898918
[patent_doc_number] => 20010047083
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-11-29
[patent_title] => 'Murine anti-idiotype antibody 3H1'
[patent_app_type] => new
[patent_app_number] => 09/797481
[patent_app_country] => US
[patent_app_date] => 2001-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 20540
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0047/20010047083.pdf
[firstpage_image] =>[orig_patent_app_number] => 09797481
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/797481 | Murine anti-idiotype antibody 3H1 | Feb 27, 2001 | Abandoned |
| 09/763985 | Novel tumor antigen protein sart-3 and tumor antigen peptide thereof | Feb 27, 2001 | Abandoned |
Array
(
[id] => 6473090
[patent_doc_number] => 20020022235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Method for diagnosing efficacy of xenotypic antibody therapy'
[patent_app_type] => new
[patent_app_number] => 09/779439
[patent_app_country] => US
[patent_app_date] => 2001-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4554
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022235.pdf
[firstpage_image] =>[orig_patent_app_number] => 09779439
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/779439 | Method for diagnosing efficacy of xenotypic antibody therapy | Feb 7, 2001 | Abandoned |
| 09/720364 | Human monoclonal antibodies against the tumor antigen uk114 and lymphocyte cells and hybridomas for their production | Feb 4, 2001 | Abandoned |
Array
(
[id] => 6514415
[patent_doc_number] => 20020026036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-28
[patent_title] => 'Process for producing humanized chimera antibody'
[patent_app_type] => new
[patent_app_number] => 09/764304
[patent_app_country] => US
[patent_app_date] => 2001-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 20437
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0026/20020026036.pdf
[firstpage_image] =>[orig_patent_app_number] => 09764304
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/764304 | Polypeptide composing human chimeric antibody | Jan 18, 2001 | Issued |
Array
(
[id] => 5844284
[patent_doc_number] => 20020132274
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Diagnostic and monitorings methods for cancer'
[patent_app_type] => new
[patent_app_number] => 09/760899
[patent_app_country] => US
[patent_app_date] => 2001-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 27406
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20020132274.pdf
[firstpage_image] =>[orig_patent_app_number] => 09760899
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/760899 | Diagnostic and monitorings methods for cancer | Jan 16, 2001 | Abandoned |
Array
(
[id] => 7051979
[patent_doc_number] => 20010001310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-05-17
[patent_title] => 'Bispecific antibodies for retargeting anticancer cytotoxic lymphocytes'
[patent_app_type] => new-utility
[patent_app_number] => 09/757336
[patent_app_country] => US
[patent_app_date] => 2001-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6817
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0001/20010001310.pdf
[firstpage_image] =>[orig_patent_app_number] => 09757336
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/757336 | Prostate cell surface antigen-specific antibodies | Jan 8, 2001 | Issued |
Array
(
[id] => 1416345
[patent_doc_number] => 06525177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-02-25
[patent_title] => 'Truncated forms of NY-ESO-1 protein'
[patent_app_type] => B2
[patent_app_number] => 09/751798
[patent_app_country] => US
[patent_app_date] => 2000-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 7
[patent_no_of_words] => 7755
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/525/06525177.pdf
[firstpage_image] =>[orig_patent_app_number] => 09751798
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/751798 | Truncated forms of NY-ESO-1 protein | Dec 28, 2000 | Issued |
| 09/751181 | Specific human antibodies for selective cancer therapy | Dec 28, 2000 | Abandoned |
Array
(
[id] => 6745862
[patent_doc_number] => 20030023045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-01-30
[patent_title] => 'Reshaped human antibody to human medulloblastoma cells'
[patent_app_type] => new
[patent_app_number] => 09/749873
[patent_app_country] => US
[patent_app_date] => 2000-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13461
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0023/20030023045.pdf
[firstpage_image] =>[orig_patent_app_number] => 09749873
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/749873 | Reshaped human antibody to human medulloblastoma cells | Dec 28, 2000 | Abandoned |
Array
(
[id] => 6638949
[patent_doc_number] => 20020086978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Specific binding agents'
[patent_app_type] => new
[patent_app_number] => 09/749831
[patent_app_country] => US
[patent_app_date] => 2000-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 7059
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086978.pdf
[firstpage_image] =>[orig_patent_app_number] => 09749831
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/749831 | Specific binding agents | Dec 27, 2000 | Abandoned |
Array
(
[id] => 5858532
[patent_doc_number] => 20020122807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-05
[patent_title] => 'Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers'
[patent_app_type] => new
[patent_app_number] => 09/747669
[patent_app_country] => US
[patent_app_date] => 2000-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25346
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0122/20020122807.pdf
[firstpage_image] =>[orig_patent_app_number] => 09747669
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/747669 | Antigen binding fragments, designated 4B5, that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers | Dec 20, 2000 | Abandoned |
| 09/508097 | Protein markers for esophageal cancer | Dec 18, 2000 | Abandoned |
Array
(
[id] => 5843466
[patent_doc_number] => 20020131968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-19
[patent_title] => 'Antibody preparation'
[patent_app_type] => new
[patent_app_number] => 09/736371
[patent_app_country] => US
[patent_app_date] => 2000-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 7667
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 30
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20020131968.pdf
[firstpage_image] =>[orig_patent_app_number] => 09736371
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/736371 | Antibody preparation | Dec 14, 2000 | Abandoned |
Array
(
[id] => 6015594
[patent_doc_number] => 20020102544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-01
[patent_title] => 'Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators'
[patent_app_type] => new
[patent_app_number] => 09/733757
[patent_app_country] => US
[patent_app_date] => 2000-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 26550
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0102/20020102544.pdf
[firstpage_image] =>[orig_patent_app_number] => 09733757
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/733757 | Novel methods of diagnosing colorectal cancer, compositions, and methods of screening for colorectal cancer modulators | Dec 7, 2000 | Abandoned |
